Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus | Zendy

Gail Matthews | Zendy; Eric C. Seaberg | Zendy; Anchalee Avihingsa | Zendy; Scott Bowden | Zendy; Gregory J. Dore | Zendy; Sharon R. Lewin | Zendy; Joe Sasadeusz | Zendy; Peter Revill | Zendy; Margaret Littlejohn | Zendy; Jennifer Hoy | Zendy; Robert Finlayson | Zendy; Kiat Ruxrungtham | Zendy; Melissa Saulynas | Zendy; Stephen Locarnini | Zendy; Chloe L. Thio | Zendy

Open Access

Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus

Author(s) -

Gail Matthews,

Eric C. Seaberg,

Anchalee Avihingsa,

Scott Bowden,

Gregory J. Dore,

Sharon R. Lewin,

Joe Sasadeusz,

Peter Revill,

Margaret Littlejohn,

Jennifer Hoy,

Robert Finlayson,

Kiat Ruxrungtham,

Melissa Saulynas,

Stephen Locarnini,

Chloe L. Thio

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit002

Subject(s) - medicine , tenofovir , human immunodeficiency virus (hiv) , virology , hepatitis b virus , antiretroviral therapy , hepatitis c virus , sida , virus , viral disease , viral load

Tenofovir (TDF) is effective for treatment of hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infection; however, some individuals have ongoing HBV viremia, the reasons for which are unclear. We determined the patterns and factors associated with detectable HBV DNA in HIV-HBV-coinfected subjects on highly active antiretroviral therapy (HAART).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research